Kimberly-Clark and Kenvue first announced the $48.7 billion deal on Nov. 5, 2025.
April 15, 2026 - Kimberly-Clark today announced the organizational structure and key leadership that will become effective upon completion of its pending acquisition of Kenvue Inc. (NYSE: KVUE).
"We are excited to name the leadership team that will guide us forward to create a new kind of health and wellness company poised to raise the standard of care for billions of consumers across every stage of life," said Mike Hsu, Chairman and Chief Executive Officer of Kimberly Clark. "Our team was selected after a thorough and thoughtful process and reflects leaders with the right blend of experience, capabilities, and technical expertise to unlock the full potential of our combined portfolio, iconic brands, and talented people."
Kimberly-Clark and Kenvue first announced the $48.7 billion deal on Nov. 5, 2025. Some of Kenvue's well-known brands include Tylenol, Aveeno, BAND-AID Brand, Johnson's, Listerine and Neutrogena.
After close, the combined company will operate with four business segments, each driving a focus on winning in its local markets:
As previously announced, Hsu will continue to serve as Chairman and CEO of the combined company. The following future leaders will report directly to Hsu:
Russ Torres, President and Chief Operating Officer of Kimberly-Clark, and Head of the Integration Management Office, stated, "Today is an important milestone that demonstrates the tremendous progress we have been making to ensure we hit the ground running on Day 1. The work of more than 30 workstreams across the integration team has identified our biggest growth and efficiency opportunities as well as the sequencing of priorities following transaction close. We are organizing to bring the best capabilities to the markets at speed and focus on the places where we can unlock significant value creation."
Hsu continued, "K-C and Kenvue have a talented and dedicated group of leaders at both companies. I am grateful to those leaders who will be transitioning from their roles at closing for their contributions and for the important role they continue to play in driving business momentum as we bring our companies together."
The transaction remains on track to close in the second half of 2026, subject to the receipt of regulatory approvals and satisfaction of other remaining customary closing conditions.
1 Represents the combined net sales of Kimberly-Clark and Kenvue for fiscal year 2025, as reported in each company's Annual Report on Form 10-K, recast to reflect the estimated impact of the new proposed segment structure.
Kimberly-Clark (NYSE: KMB) and its trusted brands are an indispensable part of life for people in more than 175 countries and territories. The company's portfolio of brands, including Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, Andrex, Pull-Ups, GoodNites, Intimus, Plenitud, Sweety, Softex, Viva and WypAll, hold No. 1 or No. 2 share positions in approximately 70 countries.
SOURCE: Kimberly-Clark